The U.S. health regulator has issued a warning letter to Medtronic Plc, highlighting certain concerns related to medical device quality management at its diabetes business, the company said on Wednesday. Medtronic’s shares were down 6 percent at $104.95 in early trading, hitting their lowest in over a year. The Food and Drug Administration’s (FDA) letter […]